Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Thromb Haemost ; 67(2): 239-47, 1992 Feb 03.
Article in English | MEDLINE | ID: mdl-1621244

ABSTRACT

Recombinant tissue-type plasminogen activator (rt-PA), produced by expression of the genomic t-PA DNA from the JMI-229 cell line, which is of rat origin, in the host cell line, was purified to homogeneity. JMI-229 rt-PA was obtained essentially as a single chain molecule which was quantitatively converted to a two-chain moiety by treatment with plasmin. The plasminogen activating potential of single chain JMI-229 rt-PA was 5-fold lower than that of commercially available human rt-PA (Actilyse) in the absence of fibrin, but comparable in the presence of fibrin; it showed a concentration-dependent binding to fibrin, with a significantly more pronounced binding than Actilyse at low fibrin concentration (85 +/- 8% versus 20 +/- 7% at 0.025 mg/ml fibrin; p = 0.004). In human plasma in the absence of fibrin, the concentrations of both single chain and two-chain JMI-229 rt-PA required to induce 50% fibrinogen degradation in 2 h, were about 15-fold higher than those of Actilyse. Both single chain and two-chain forms of JMI-229 rt-PA and of Actilyse induced a similar time- and concentration-dependent lysis of a 125I-fibrin-labeled plasma clot immersed in human plasma, in the absence of significant systemic fibrinolytic activation. Equally effective concentrations (causing 50% clot lysis in 2 h) were 0.11 or 0.10 micrograms/ml for single chain or two-chain JMI-229 rt-PA, as compared to 0.11 or 0.15 micrograms/ml for single chain or two-chain Actilyse.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Fibrin/metabolism , Tissue Plasminogen Activator/chemistry , Amides/metabolism , Animals , Cell Line , Cricetinae , Fibrinolysis/drug effects , Humans , In Vitro Techniques , Kinetics , Plasminogen/metabolism , Plasminogen Inactivators/metabolism , Protein Binding , Pulmonary Embolism/metabolism , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Tissue Plasminogen Activator/pharmacokinetics , Tissue Plasminogen Activator/pharmacology
2.
Vet Rec ; 111(14): 316-8, 1982 Oct 02.
Article in English | MEDLINE | ID: mdl-6293150

ABSTRACT

A study was carried out on the bacteriological faecal flora of horses before and after oral doses of oxytetracycline or trimethoprim plus sulphadiazine. Administration of oxytetracycline was rapidly followed by large increases in counts of coliforms. Bacteroides and Streptococcus species, the disappearance of Veillonella species, the appearance of Clostridium perfringens type A in large numbers and the accumulation of watery fluid in the rectal contents. These changes were not seen following administration of trimethoprim-sulphadiazine and it was concluded that oral treatment of horses with this combination was unlikely to be accompanied by the hazard of inducing colitis.


Subject(s)
Bacteria/drug effects , Horses/microbiology , Oxytetracycline/pharmacology , Sulfadiazine/pharmacology , Trimethoprim/pharmacology , Administration, Oral , Animals , Bacteroides/drug effects , Clostridium perfringens/drug effects , Drug Combinations , Enterobacteriaceae/drug effects , Feces/microbiology , Male , Species Specificity , Streptococcus/drug effects , Veillonella/drug effects
3.
J Med Eng Technol ; 14(4): 143-54, 1990.
Article in English | MEDLINE | ID: mdl-2398486

ABSTRACT

This paper describes the results of a survey which investigated and evaluated the needs and abilities of electric wheelchair users. The results of this survey will be used to develop a low-cost electric wheelchair-mounted robotic arm for use by physically disabled people to facilitate rehabilitation. The survey was undertaken by the author together with staff and students from occupational therapist training colleges, using a four-page questionnaire containing over 110 questions. The questionnaire was developed by the author together with Dr Robin Platts (Director of Orthotics), Mr Ian Bayley (Director of the London Spinal Unit) and senior occupational therapists at the Royal National Orthopaedic Hospital, Stanmore, Middlesex. After a successful trial the questionnaire was used with 50 severely disabled people from various backgrounds and social circumstances. The results of this survey show that the average electric wheelchair user is 40 years old, single (68%), living at home (58%) with family support (69%) and without any paid employment (79%). The most prevalent disability is spinal cord injury (24%) followed by multiple sclerosis (16%). The survey has identified several tasks which electric wheelchair users find impossible to do, and some of these will form part of the design specification. Finally 84% of the survey subjects would consider buying such a robotic aid.


Subject(s)
Robotics , Self-Help Devices , Wheelchairs , Activities of Daily Living , Adolescent , Adult , Employment , Equipment Design , Female , Humans , Male , Marriage , Middle Aged , Surveys and Questionnaires
4.
5.
Eur J Biochem ; 153(1): 137-44, 1985 Nov 15.
Article in English | MEDLINE | ID: mdl-3933977

ABSTRACT

Copper(I), copper(II) and silver ions have been shown to be potent inhibitors of purified soluble methane monooxygenase (MMO) of Methylococcus capsulatus (Bath). A weaker inhibition has been observed with zinc and cadmium ions. Proteins A and B of soluble MMO are unaffected by copper but protein C is rapidly and irreversibly inhibited. The site of copper inhibition has been shown to be primarily at the iron-sulphur centre of protein C with a secondary effect at the FAD centre when the copper(II):protein C ratio is high. Copper appears to bring about the inhibition of soluble MMO by interacting with protein C to disrupt the protein structure causing, firstly, the loss of the iron-sulphur centre, preventing the transfer of electrons from protein C to protein A, and secondly, the loss of FAD preventing the protein from accepting electrons from NADH. Inhibition and spectral data are provided to support this thesis. The inactivation of protein C is associated with the tight binding of four Cu atoms to each protein C molecule. These data extend our knowledge of how copper, which is known to have a key role in the cellular location of MMO, interacts with and rapidly and irreversibly inactivates the soluble form of this enzyme.


Subject(s)
Copper/pharmacology , Methylococcaceae/enzymology , Oxygenases/antagonists & inhibitors , Binding Sites , Metals/pharmacology , NAD/metabolism , Protein Binding , Protein Conformation , Solubility , Spectrometry, Fluorescence , Spectrophotometry
SELECTION OF CITATIONS
SEARCH DETAIL